These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29339727)

  • 1. Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia.
    Mozas P; Rivas-Delgado A; Baumann T; Villamor N; Ortiz-Maldonado V; Aymerich M; Costa D; Navarro A; Giné E; López-Guillermo A; Montserrat E; Delgado J
    Blood Cancer J; 2018 Jan; 8(1):10. PubMed ID: 29339727
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients.
    Tedeschi A; Rossi D; Motta M; Quaresmini G; Rossi M; Coscia M; Anastasia A; Rossini F; Cortelezzi A; Nador G; Scarfò L; Cairoli R; Frustaci AM; Dalceggio D; Picardi P; De Paoli L; Orlandi E; Rambaldi A; Massaia M; Gaidano G; Montillo M;
    Haematologica; 2015 Dec; 100(12):e501-4. PubMed ID: 26294723
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia.
    Visentin A; Gurrieri C; Imbergamo S; Lessi F; Di Maggio SA; Frezzato F; Adami F; Zambello R; Piazza F; Semenzato G; Trentin L
    Hematol Oncol; 2017 Dec; 35(4):925-928. PubMed ID: 27641225
    [No Abstract]   [Full Text] [Related]  

  • 4. All is not lost--the improving outcome of patients with chronic lymphocytic leukaemia failing frontline therapy with fludarabine, cyclophosphamide and rituximab.
    Cheah CY; Lew TE; Lee R; Tam CS; Seymour JF; Carney DA
    Eur J Haematol; 2013 Aug; 91(2):189-90. PubMed ID: 23668259
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of age and comorbidities on the efficacy of FC and FCR regimens in chronic lymphocytic leukemia.
    Strugov V; Stadnik E; Virts Y; Andreeva T; Zaritskey A
    Ann Hematol; 2018 Nov; 97(11):2153-2161. PubMed ID: 29946909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FCA: forget chemoimmunotherapy with alemtuzumab?
    Hallek M
    Blood; 2012 May; 119(22):5059-60. PubMed ID: 22653949
    [No Abstract]   [Full Text] [Related]  

  • 7. Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
    Ayyildiz O; Isikdogan A; Bolaman Z; Muftuoglu E
    Saudi Med J; 2004 Dec; 25(12):2054-6. PubMed ID: 15711709
    [No Abstract]   [Full Text] [Related]  

  • 8. Agranulocytosis occurring in a patient with chronic lymphocytic leukemia in complete remission; treatment by rituximab and cyclosporin.
    Costello RT; Sébahoun G
    Leuk Res; 2010 Dec; 34(12):e329-30. PubMed ID: 20723978
    [No Abstract]   [Full Text] [Related]  

  • 9. A phase I dose-ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities.
    Danilov AV; Lewis LD; Lansigan F; Roudaia L; Findley DL; Jones SY; Highhouse B; Beaulieu BB; Brown JR
    Br J Haematol; 2017 Sep; 178(5):820-823. PubMed ID: 27377970
    [No Abstract]   [Full Text] [Related]  

  • 10. Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era.
    Mato A; Jahnke J; Li P; Mehra M; Ladage VP; Mahler M; Huntington S; Doshi JA
    Haematologica; 2018 Oct; 103(10):e462-e465. PubMed ID: 29700170
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
    Del Principe MI; Dal Bo M; Bittolo T; Buccisano F; Rossi FM; Zucchetto A; Rossi D; Bomben R; Maurillo L; Cefalo M; De Santis G; Venditti A; Gaidano G; Amadori S; de Fabritiis P; Gattei V; Del Poeta G
    Haematologica; 2016 Jan; 101(1):77-85. PubMed ID: 26565002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine combined with cyclophosphamid is highly effective in the treatment of chronic lymphocytic leukemia.
    Tóthová E; Kafková A; Fricová M; Guman T; Stecová N
    Neoplasma; 2003; 50(6):433-7. PubMed ID: 14689065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte recovery is impaired in patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas treated with bendamustine plus rituximab.
    García Muñoz R; Izquierdo-Gil A; Muñoz A; Roldan-Galiacho V; Rabasa P; Panizo C
    Ann Hematol; 2014 Nov; 93(11):1879-87. PubMed ID: 24951124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to improve the treatment outcome in chronic lymphocytic leukemia?
    Robak T
    Leuk Res; 2010 Mar; 34(3):272-5. PubMed ID: 19682742
    [No Abstract]   [Full Text] [Related]  

  • 15. Pseudohyperkalemia in chronic lymphocytic leukemia.
    Ruddy KJ; Wu D; Brown JR
    J Clin Oncol; 2008 Jun; 26(16):2781-2. PubMed ID: 18509189
    [No Abstract]   [Full Text] [Related]  

  • 16. Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia.
    Kay NE; LaPlant BR; Pettinger AM; Call TG; Leis JF; Ding W; Parikh SA; Conte MJ; Bowen DA; Shanafelt TD
    Expert Rev Hematol; 2018 Apr; 11(4):337-349. PubMed ID: 29460654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic erythropoietin-induced polycythemia associated with small lymphocytic lymphoma.
    Al-Tourah AJ; Tsang PW; Skinnider BF; Hoskins PJ
    J Clin Oncol; 2006 May; 24(15):2388-9. PubMed ID: 16710039
    [No Abstract]   [Full Text] [Related]  

  • 18. Bendamustin-Rituximab Combination Is a Safe and Effective, Ambulatory Treatment for Elderly Patients with Chronic Lymphocytic Leukemia: Retrospective Real-world Analysis by Age from a German Registry and Review of the Literature.
    Kleeberg UR; Linde H; Günther G; Tessen HW; Kersting M
    Anticancer Res; 2016 Jun; 36(6):2827-38. PubMed ID: 27272794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Willis CR; Goodrich A; Park K; Waselenko JK; Lucas M; Reese A; Diehl LF; Grever MR; Byrd JC; Flinn IW
    Ann Hematol; 2006 May; 85(5):301-7. PubMed ID: 16518606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Agents for the Frontline Management of Chronic Lymphocytic Leukemia.
    Burger JA
    Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 8):7-12. PubMed ID: 27168204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.